>T2LEC5 Lambda-crystallin (EC 1.1.1.45)
MTARIGIIGAGLIGRAWAIVFARSGMSVCLYDVDASALSQVRDGIRQSLQDLFQAGLIED
IEVPLSLIQTENNLAHAMRDVEYVQECGPEDIDAKRRIYSELESVVAIDTVLASSTSGIA
ASRFTNHLKHPERCLVAHPVNPPYLIPLVEVAPSPDTSEAAVNRTMQLMEQAQQTPILVR
KEVQGFILNRLQGALLNEALRLFRDGYVSAEDLDKTVKHGLGLRWSFMGPFETIDLNAPN
GVVDYGQRYGPLYRDVDRQRSDDDPWDTATLAALGQERRSQLPSEGLAERQAWRDRRLMA
LMAHQRHIDTK
>F7SA26 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.45)
MKIAVVGAGLVGSAWAIVFARAGHDVAVYDAVEGGADRAIGLIGDRLKTLEEVGLIEDAA
AAGQRVRVAASLADAVVDAAYIQESVFETVEQKRQIFAALDAVVGPETLIGSSSSGIPAS
AFTDHVGCRERCLIAHPVNPPYLIPVVELVPAPWTAAATVQRVRALMESVGQEPVELTRE
IEGFALNRLQGLLLAEAWKLVADGIMSVEDVDRTVSAGLGLRWSFMGPFETIDLNAPGGV
ADYARRFRTMYETIAGSRGVDLGWDDALIAEVERQRRVALPADQLAERSAWRDRRLMALM
AHKRSSQDPAAG
>C0RLY7 Type I restriction-modification system, M subunit (EC 1.1.1.45)
MAKLTRTELENHLWKSADILRGSIDSSDYKIYIFGFLFLKRLSDRFEEEAKESIRQGLPE
NVAYSDPDEHEFFLVERARWSSIKKLTTGIGDHLNKACAAIEDANPSIEGVLANIDFNSE
SRLGDAKNREGVLSRLIDHFSRIDLSNASLSEPDMLGRAYEYLIDKFADDAGKKGGEFYT
PHHVVRLIVELLAPKPGMRISDPTCGSGGMLVQVAEHVAKLEGKRLGEALNITLHGQEKN
LGTWAIAKMNLLLHGLRDARIEKGDTIRNPRLLDQDGNLFLYDRVIANPPFSLDSWGAED
VSGDTEKKGHNRFIYGIPPKNMGDLAFVQHMVATLNTKGVCGVVMPHGVLFRGSGDGRIR
ESMLKADLFEAIIGLPENLFAGTGIPATVLILNKAKATERKGRVLFIHGAKEFEERPKKN
ILGEGNITRIVNAFNAWKDEDRFCRIVDMKEIEENDFNLNISRYIDTLEPEKPIDVQAEL
AKLWDAETARDEAAARMNALLKEMGYVG
>C4IV19 Type I restriction-modification system, M subunit (EC 1.1.1.45)
MTRACLATTRIIEVNMAKLTRTELENHLWKSADILRGSIDSSDYKIYIFGFLFLKRLSDR
FEEEAKESIRQGLPENVAYSDPDEHEFFLVERARWSSIKKLTTGIGDHLNKACAAIEDAN
PSIEGVLANIDFNSESRLGDAKNREGVLSRLIDHFSRIDLSNASLSEPDMLGRAYEYLID
KFADDAGKKGGEFYTPHHVVRLIVELLAPKPGMRISDPTCGSGGMLVQVAEHVAKLEGKR
LGEALNITLHGQEKNLGTWAIAKMNLLLHGLRDARIEKGDTIRNPRLLDQDGNLFLYDRV
IANPPFSLDSWGAEDVSGDTEKKGHNRFIYGIPPKNMGDLAFVQHMVATLNTKGVCGVVM
PHGVLFRGSGDGRIRESMLKADLFEAIIGLPENLFAGTGIPATVLILNKAKATERKGRVL
FIHGAKEFEERPKKNILGEGNITRIVNAFNAWKDEDRFCRIVDMKEIEENDFNLNISRYI
DTLEPEKPIDVQAELAKLWDAETARDEAAARMNALLKEMGYVG
>C0GAI3 Type I restriction-modification system, M subunit (EC 1.1.1.45)
MTRACLATTRIIEVNMAKLTRTELENHLWKSADILRGSIDSSDYKIYIFGFLFLKRLSDR
FEEEAKESIRQGLPENVAYSDPDEHEFFLVKRARWSSIKKLTTGIGDHLNKACAAIEDAN
PSIEGVLANIDFNSESRLGDAKNREGVLSRLIDHFSRIDLSNASLSEPDMLGRAYEYLID
KFADDAGKKGGEFYTPHHVVRLIVELLAPKPGMRISDPTCGSGGMLVQVAEHVAKLEGKR
LGEALNITLHGQEKNLGTWAIAKMNLLLHGLRDARIEKGDTIRNPRLLDQDGNLFLYDRV
IANPPFSLDSWGAEDVSGDTEKKGHNRFIYGIPPKNMGDLAFVQHMVATLNTKGVCGVVM
PHGVLFRGSGDGRIRESMLKADLFEAIIGLPENLFAGTGIPATVLILNKAKATERKGRVL
FIHGAKEFEERPKKNILGEGNITRIVNAFNAWKDEDRFCRIVDMKEIEENDFNLNISRYI
DTLEPEKPIDVQAELAKLWDAETARDEAAARMNALLKEMGYVG
>Q9R4S4 (S)-3-HYDROXYCARBOXYLATE oxidoreductase (EC 1.1.1.45) (Fragment)
MNIKSISVLGTGTMGHGIALFSSMAGLNVTMYGRSDAXLKTGFXA
